Stefania Zona
London, ENG W120NN, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.
Journal: Cell death & disease
Published: May 26, 2021
Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells.
Journal: Oncogene
Published: February 15, 2019
FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.
Journal: Cell death & disease
Published: June 11, 2018
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: January 19, 2018
SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells.
Journal: Oncogenesis
Published: September 26, 2017
ER stress and cancer: The FOXO forkhead transcription factor link.
Journal: Molecular and cellular endocrinology
Published: March 24, 2017
FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
Journal: Oncogene
Published: March 31, 2016
FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance.
Journal: Cellular signalling
Published: July 30, 2015
Last Updated: 09/26/2026